Rise in Prevalence of Genetic Diseases Expected to Drive Global Proteomics Market: Ken Research

0


Proteomics referred as the study of proteomes, which is a set of proteins that is produced in an organism, system, or any biological context. They may vary from cell to cell and changes over a specific period of time. They are used in various applications such as in transcriptional & post transcriptional studies, to investigate protein expression, metabolic pathways, to study localization of sub cellular proteins, to study protein interaction in diseases viz. cancer etc. Proteomics can be studied using various technologies including gel-based techniques, mass spectrometry, and others.

According to study, “Proteomics Market Global Report 2020-30” the key companies operating in the global proteomics market are Thermo Fisher Scientific, Inc.; Merck KGaA; Waters Corporation; Perkinelmer, Inc.; Agilent Technologies, Inc.; Danaher Corporation;  Bio-Rad Laboratories, IncCaprion Biosciences; Luminex Corporation; .; Bruker Corporation; GE Healthcare; LI-COR, Inc.; Siemens Ltd; Genzyme Corporation; Creative Proteomics; Becton, Dickinson and Company; Promega Corporation

Based on instrumentation technology, proteomics market is segmented as spectroscopy, protein microarrays, chromatography, x-ray crystallography, electrophoresis protein fractionation and surface Plasmon resonance. Spectroscopy includes NMR spectroscopy, mass spectroscopy, and CD spectroscopy. Protein microarrays include microarray instruments (arrayers, integrated systems and microarray scanners) and biochips (lab-on-chips and protein chips). Chromatography includes Ion chromatography, HPLC, supercritical fluid chromatography and affinity chromatography.  Electrophoresis includes capillary electrophoresis and gel electrophoresis. Based on reagent, market is segmented as spectroscopy reagents, immunoassay reagents, protein microarray reagents, electrophoresis reagents, x-ray crystallography reagents, protein fractionation reagents, chromatography reagents. Based on software & services, market is segmented as bioinformatics software & services and core proteomics services. Bioinformatics software & services are further sub-segmented as bioinformatics tools, bioinformatics databases and bioinformatics services. Core proteomics services are further sub-segmented as protein separation services, protein identification services, protein sequencing services, custom assay services, protein characterization services, quantitative proteomic services and others. In addition, based on application, market is segmented as clinical diagnostics (diabetes, cancer, cardiovascular diseases, infectious diseases, immune diseases, neurological disorders and others), drug discovery (preclinical studies, lead optimization, lead identification and target discovery) and others.

The proteomics market is driven by rise in demand for advanced diagnostics in targeted disease treatment, followed by increase in geriatric population demanding personalized medicines, rise in prevalence of target diseases and increase in pharmaceutical & biotechnology Research & Development (R&D) expenditure and government funding for proteomics. However, low biomarker discovery-to-approval ratio and high cost of instruments may impact the market. Moreover, personalized proteomics for precision health and growth in prominence of nanoproteomics are key opportunities for market.

Based on geography, the North-American region holds major share in global proteomics market owing to increase in research activities, rise in government funding, improved healthcare infrastructure, rise in awareness regarding applications of proteomics, increase in prevalence of cancer and increase in health care expenditure in the region. Whereas, the Asian-Pacific and European regions are anticipated to witness higher growth rate due to increase in cancer research activities and presence of key market players over the forecast period. It is estimated that future of the global market will be optimistic as a result of presence of a large number of drug manufactures globally during the forecast period. The global proteomics market was valued at US $18.01 billion in 2019 and it is expected to grow at a CAGR of 14.79% and reach at US $31.28 billion by 2023.

For More Information, Click on the Link Below:-

Global Proteomics Market

Contact Us:-

Ken Research

Ankur Gupta, Head Marketing & Communications

Ankur@kenresearch.com

+91-9015378249

Share.

Comments are closed.